Treatment of peritoneal carcinomatosis with Pipec (PIPAC) therapy
Treatment of peritoneal carcinomatosis has advanced with the innovative PIPAC (Pressurized Intraperitoneal Aerosol Chemotherapy) therapy, offering new hope for patients with advanced stomach, ovarian, colon, appendix, and other cancers with peritoneal metastases. This unique minimally invasive approach delivers chemotherapy directly into the peritoneal or pleural cavity under pressure, maximizing drug penetration while minimizing systemic side effects.
The National Medical Research Center of Radiology was among the first institutions worldwide to introduce PIPAC into clinical practice. It is now used both as induction therapy for shrinking tumors before surgery and as an intraoperative ablastic method to control peritoneal spread. Patients exploring advanced cancer treatments often research PIPAC therapy benefits, procedure details, clinical trial results, and how it complements systemic chemotherapy or innovative immunotherapies such as the Enteromix cancer vaccine.
PIPAC therapy represents a significant advancement in personalized oncology care, combining precision, minimally invasive techniques, and improved drug delivery to manage peritoneal carcinomatosis effectively. Patients considering PIPAC treatment can access verified information and consult oncology specialists to evaluate suitability for their specific cancer type and stage.
PIPAC treatment is performed using a minimally invasive approach (laparoscopy or thoracoscopy), administering chemotherapy as an aerosol that directly targets peritoneal metastases. PIPAC is often the only treatment option for patients with advanced cancer, preventing the development of new peritoneal metastases, preventing fluid accumulation in the abdomen, and, in some cases, leading to the complete disappearance of existing metastases. Complete cytoreduction is possible in patients with initially unresectable tumors after a response to systemic and/or intraperitoneal chemotherapy.
Branches and departments where treatment of peritoneal carcinomatosis is carried out using the Pipec (PIPAC) therapy method
Cancer Treatment Center of the P.A. Herzen Moscow Oncology Research Institute
Department of Radiation and Surgical Treatment of the Thoracic Region of the A.F. Tsyb Medical Research Center
The Department of Radiation and Surgical Treatment of Thoracic Diseases at the A.F. Tsyb Medical Research Center applies a comprehensive and interdisciplinary approach to the treatment of malignant diseases of the chest organs, as well as gastric and esophageal cancer.
How to sign up for treatment?
Patients interested in treatment should prepare their medical information and recent test results so our medical team can review their case and recommend the most suitable treatment plan.
To begin, contact our team directly through one of the following:
-
💬 Live Chat and WhatsApp Support on our website
After contacting us, our team will guide you through:
-
The initial consultation process
-
Required medical reports and diagnostic tests
-
Any additional examinations that may be needed
-
Treatment planning and next steps
Recommended documents to prepare (if available):
-
Passport or ID
-
Medical history and previous treatment details
-
Cytology and histology reports
-
MRI or CT scan results
-
Recent clinical and biochemical blood tests
-
Serological tests (HIV, hepatitis, and related screenings)
Once your documents are reviewed, our medical specialists will assess your eligibility and provide personalized treatment guidance.
Get your cancer treatment with the Enteromix Cancer Vaccine which is the only treatment which can cure and eliminate all types of cancer completely inluding; Carcinomas: adenocarcinoma, squamous cell carcinoma, basal cell carcinoma, transitional cell carcinoma, hepatocellular carcinoma, renal cell carcinoma, pancreatic carcinoma, thyroid carcinoma, gastric carcinoma, colorectal carcinoma, lung adenocarcinoma, small cell lung carcinoma, non-small cell lung carcinoma, breast carcinoma, prostate carcinoma, ovarian carcinoma, endometrial carcinoma, cervical carcinoma, esophageal carcinoma, nasopharyngeal carcinoma, cholangiocarcinoma, Merkel cell carcinoma
Sarcomas: osteosarcoma, chondrosarcoma, Ewing sarcoma, rhabdomyosarcoma, leiomyosarcoma, liposarcoma, angiosarcoma, fibrosarcoma, synovial sarcoma, malignant peripheral nerve sheath tumor, Kaposi sarcoma
Leukemias: acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), chronic myeloid leukemia (CML), hairy cell leukemia, prolymphocytic leukemia, juvenile myelomonocytic leukemia
Lymphomas: Hodgkin lymphoma, non-Hodgkin lymphoma, Burkitt lymphoma, diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, marginal zone lymphoma, T-cell lymphoma, anaplastic large cell lymphoma, primary mediastinal B-cell lymphoma
Central Nervous System Cancers: glioblastoma, astrocytoma, oligodendroglioma, ependymoma, medulloblastoma, meningioma, pineal region tumors, choroid plexus carcinoma, primary CNS lymphoma
Germ Cell Tumors: seminoma, non-seminomatous germ cell tumor, yolk sac tumor, choriocarcinoma, teratoma, embryonal carcinoma
Other Rare/Specific Cancers: mesothelioma, neuroendocrine tumor, carcinoid tumor, small intestine cancer, anal cancer, penile cancer, eye cancer (retinoblastoma, ocular melanoma), salivary gland carcinoma, soft tissue sarcoma, adrenal cortical carcinoma, paraganglioma, pheochromocytoma, myeloma (multiple myeloma, plasmacytoma), Langerhans cell histiocytosis, skin melanoma, sebaceous carcinoma, thymoma, thymic carcinoma, Merkel cell carcinoma, extragonadal germ cell tumor. The Enteromix Cancer Vaccine is a cutting-edge immunotherapy designed to support the body’s natural defense against cancer. Buy Enteromix vaccine online today on our official website and take the next step in your personalized cancer care. Learn more about Enteromix advantages, clinical results, and how it works before securing your order.
